Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Biol Macromol ; 147: 1125-1135, 2020 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-31739069

RESUMEN

A new neutral polysaccharide, named AGP, was extracted from glycyrrhiza residue by 5% NaOH alkaline solution and purified by DEAE-celluloseand Sephadex G-150. A single and symmetrical peak was shown by HPLC, indicating that AGP is a homogeneous polysaccharide with a molecular weight of 2.89 × 103 KDa. Thespecific rotation of AGP was detected by a polarimeter and it was +45°. Monosaccharide composition analysis indicated that AGP was consisted of l-rhamnose: l-arabinose: d-xylose: d-mannose: d-glucose and d-galactose with a molar ratio of 1:2.33:2.85:0.69:3.05:1.54. The structure of AGP was analyzed by GC-MS, periodate oxidation, Smith degradation, FT-IR, methylation and NMR, which indicated that the AGP was composed of → 6)-ß-d-Glcp-( â†’ backbone and the â†’4)-α-d-Xylp-(1→, →5)-α-l-Araf-(1→, →3)-α-l-Rhap-(1→, →6)-α-d-Galp-(1→, →3,6)-α-Manp-(1→ and →1)-ß-d-Glcp as branches. The results of Congo red experiment and circular dichroism (CD) showed that there was triple helix conformation in AGP. The micro-structure of AGP were detected by scanning electron microscopy (SEM), which concluded that the shape of AGP was a "thin slice" and its structure is not regular. The crystal configuration was identified by X-ray diffraction (XRD), showing that there is no crystal structure. Furthermore, the AGP exhibited certain inhibition activity on α-glucosidase.


Asunto(s)
Inhibidores de Glicósido Hidrolasas/química , Glycyrrhiza/química , Polisacáridos/química , alfa-Glucosidasas/metabolismo , Dicroismo Circular , DEAE-Celulosa/química , Etanolaminas/química , Espectroscopía de Resonancia Magnética , Metilación , Microscopía Electrónica de Rastreo , Peso Molecular , Monosacáridos/química , Oxígeno/química , Ácido Peryódico/química , Extractos Vegetales/química , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier , Ácidos Urónicos/química , Difracción de Rayos X
2.
Nutr Hosp ; 28(6): 2124-7, 2013 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-24506391

RESUMEN

PURPOSE: To evaluate the effects of total parenteral nutrition and octreotide on pediatric patients with chylous ascites post-operative. METHODS: Four patients were diagnosed with chylous ascites from Nov 2009 to Nov 2012. Total parenteral nutrition and octreotide was administered to 2 patients, while the other two only received fasting and total parenteral nutrition. All patients had persistent peritoneal drainage, with the quantity and quality of drainage fluid observed daily. RESULTS: Two patients who received somatostatin therapy completely recovered within 7d without any recurrence while on a normal diet. The other two patients who only received fasting and total parenteral nutrition was cured 24-30 d after therapy. CONCLUSION: Total parenteral nutrition along with octreotide can relieve the symptoms and close the chyle leakage in patients with chylous ascites rapidly. It seems to be an effective therapy available for the treatment of chylous ascites.


Purpose: To evaluate the effects of total parenteral nutrition and octreotide on pediatric patients with chylous ascites post-operative. Methods: Four patients were diagnosed with chylous ascites from Nov 2009 to Nov 2012. Total parenteral nutrition and octreotide was administered to 2 patients, while the other two only received fasting and total parenteral nutrition. All patients had persistent peritoneal drainage, with the quantity and quality of drainage fluid observed daily. Results: Two patients who received somatostatin therapy completely recovered within 7d without any recurrence while on a normal diet. The other two patients who only received fasting and total parenteral nutrition was cured 24-30d after therapy. Conclusion: Total parenteral nutrition along with octreotide can relieve the symptoms and close the chyle leakage in patients with chylous ascites rapidly. It seems to be an effective therapy available for the treatment of chylous ascites.


Asunto(s)
Ascitis Quilosa/tratamiento farmacológico , Ascitis Quilosa/terapia , Fármacos Gastrointestinales/uso terapéutico , Octreótido/uso terapéutico , Nutrición Parenteral Total/métodos , Preescolar , Femenino , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA